The ETS transcription factor MEF is a candidate tumor suppressor gene on the X chromosome - PubMed (original) (raw)
. 2002 Nov 15;62(22):6579-86.
Affiliations
- PMID: 12438253
The ETS transcription factor MEF is a candidate tumor suppressor gene on the X chromosome
Yoshiyuki Seki et al. Cancer Res. 2002.
Abstract
Although X chromosome transfer experiments indicated that tumor suppressor genes are present on the X chromosome, they have not been previously identified. In this report, we show that the ETS transcription factor MEF (ELF4), which is located on chromosome Xq26.1, possesses tumor suppressive capability. MEF expression was up-regulated by 5-azacytidine in some cancer cell lines. MEF overexpression induced morphological changes, such as the conversion of normally loose cell-cell contacts to strong interactions similar to those seen in the presence of matrix metalloproteinase (MMP) inhibitor BB94. In the colony formation assay, A549 cells, but not MEF-overexpressing cells, formed colonies in soft agar culture. Furthermore, MEF-overexpressing cells s.c. injected in the nude mice did not grow, whereas the control cells did. The A549 tumors were poorly differentiated, whereas the MEF-overexpressing tumors were well differentiated. By immunostaining with CD31, a marker on vascular endothelial cells, we found that tumor angiogenesis was significantly suppressed in the tumors formed from MEF-overexpressing cells. In addition, the conditioned media from A549 cell cultures stimulated the migration of human umbilical vein endothelial cells, whereas conditioned media from MEF-overexpressing cell cultures had less of an effect. By gelatin zymography, Western blotting analysis, and immunohistochemistry, we found that the expression levels of MMP-9 and MMP-2 were significantly reduced in MEF-overexpressing tumors. Immunohistochemical analyses showed that interleukin (IL)-8 expression was reduced in the MEF-overexpressing tumors in nude mice. Furthermore, IL-8 mRNA expression in vitro was significantly down-regulated in MEF-overexpressing cells, compared with A549 cells. MEF suppressed the transcription and promoter activities of the genes encoding MMP-9 and IL-8, whereas ETS-2 up-regulated these activities. Therefore, we propose that MEF is a candidate tumor suppressor gene on the X chromosome with activities that are opposite to those of ETS-2.
Similar articles
- Tumor promoting properties of the ETS protein MEF in ovarian cancer.
Yao JJ, Liu Y, Lacorazza HD, Soslow RA, Scandura JM, Nimer SD, Hedvat CV. Yao JJ, et al. Oncogene. 2007 Jun 7;26(27):4032-7. doi: 10.1038/sj.onc.1210170. Epub 2007 Jan 8. Oncogene. 2007. PMID: 17213815 - Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
Detwiller KY, Fernando NT, Segal NH, Ryeom SW, D'Amore PA, Yoon SS. Detwiller KY, et al. Cancer Res. 2005 Jul 1;65(13):5881-9. doi: 10.1158/0008-5472.CAN-04-4078. Cancer Res. 2005. PMID: 15994966 - The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p.
Banham AH, Beasley N, Campo E, Fernandez PL, Fidler C, Gatter K, Jones M, Mason DY, Prime JE, Trougouboff P, Wood K, Cordell JL. Banham AH, et al. Cancer Res. 2001 Dec 15;61(24):8820-9. Cancer Res. 2001. PMID: 11751404 - [Does the c-ets 1 oncogene participate in the regulation of tumor angiogenesis?].
Vandenbunder B, Wernert N, Stehelin D. Vandenbunder B, et al. Arch Inst Pasteur Tunis. 1994 Jul-Oct;71(3-4):493-509. Arch Inst Pasteur Tunis. 1994. PMID: 8801851 Review. French. - Ribozyme-mediated repair of RNAs encoding mutant tumor suppressors.
Sullenger BA. Sullenger BA. Cytokines Mol Ther. 1996 Sep;2(3):201-5. Cytokines Mol Ther. 1996. PMID: 9384705 Review.
Cited by
- βTrCP controls the lysosome-mediated degradation of CDK1, whose accumulation correlates with tumor malignancy.
Herrero-Ruiz J, Mora-Santos M, Giráldez S, Sáez C, Japón MA, Tortolero M, Romero F. Herrero-Ruiz J, et al. Oncotarget. 2014 Sep 15;5(17):7563-74. doi: 10.18632/oncotarget.2274. Oncotarget. 2014. PMID: 25149538 Free PMC article. - Inactivation of X-linked tumor suppressor genes in human cancer.
Liu R, Kain M, Wang L. Liu R, et al. Future Oncol. 2012 Apr;8(4):463-81. doi: 10.2217/fon.12.26. Future Oncol. 2012. PMID: 22515449 Free PMC article. Review. - Mutations in the nucleolar phosphoprotein, nucleophosmin, promote the expression of the oncogenic transcription factor MEF/ELF4 in leukemia cells and potentiates transformation.
Ando K, Tsushima H, Matsuo E, Horio K, Tominaga-Sato S, Imanishi D, Imaizumi Y, Iwanaga M, Itonaga H, Yoshida S, Hata T, Moriuchi R, Kiyoi H, Nimer S, Mano H, Naoe T, Tomonaga M, Miyazaki Y. Ando K, et al. J Biol Chem. 2013 Mar 29;288(13):9457-67. doi: 10.1074/jbc.M112.415703. Epub 2013 Feb 7. J Biol Chem. 2013. PMID: 23393136 Free PMC article. - DNA demethylation-dependent enhancement of toll-like receptor-2 gene expression in cystic fibrosis epithelial cells involves SP1-activated transcription.
Furuta T, Shuto T, Shimasaki S, Ohira Y, Suico MA, Gruenert DC, Kai H. Furuta T, et al. BMC Mol Biol. 2008 Apr 21;9:39. doi: 10.1186/1471-2199-9-39. BMC Mol Biol. 2008. PMID: 18423053 Free PMC article. - The transcription factor MEF/Elf4 is dually modulated by p53-MDM2 axis and MEF-MDM2 autoregulatory mechanism.
Suico MA, Fukuda R, Miyakita R, Koyama K, Taura M, Shuto T, Kai H. Suico MA, et al. J Biol Chem. 2014 Sep 19;289(38):26143-26154. doi: 10.1074/jbc.M114.580209. Epub 2014 Jul 31. J Biol Chem. 2014. PMID: 25081543 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous